USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE
摘要
<p>This invention is directed to the use of ranolazine to reduce the risk of adverse coronary events in a mammalian patient. Typically, the natriuretic peptide is associated with coronary disease, acute coronary syndrome, and/or diastolic dysfunction. Ranolazine may be administered to the patient as an intravenous solution or in an oral dose.</p>
申请公布号
WO2008116083(A1)
申请公布日期
2008.09.25
申请号
WO2008US57686
申请日期
2008.03.20
申请人
CV THERAPEUTICS, INC.;BLACKBURN, BRENT;JERLING, MARCUS;WOLFF, ANDREW